Intrauterine pressure monitoring for augmentation or induction of labour with intravenous oxytocin: benefits and costs
- Conditions
- Pregnancy, labourPregnancy and ChildbirthLabour
- Registration Number
- ISRCTN13667534
- Lead Sponsor
- Academic Medical Centre (AMC) (Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 1350
Women with the indication to induce labour or to stimulate the contractions with intravenous oxytocin in case of arrest of labour.
1. Women with a history of caesarean section
2. Gestational age less than 36 weeks
3. Intrauterine foetal death
4. Breech presentation
5. Multiple pregnancy
6. Maternal age greater than 18 years
7. Human immunodeficiency virus (HIV) or hepatitis B infection
8. Intrauterine infection
9. Contraindication for amniotomy
10. Participation in another randomised controlled trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of instrumental deliveries, i.e. caesarean sections and/or assisted vaginal delivery.
- Secondary Outcome Measures
Name Time Method 1. The occurrence of neonatal admittance to Neonatal Intensive Care Unit (NICU)<br>2. Need for antibiotics by mother or child<br>3. Total amount of oxytocin used<br>4. Complications<br>5. Time to delivery and costs